Table of Contents
Leukemia Research and Treatment
Volume 2012, Article ID 262363, 4 pages
http://dx.doi.org/10.1155/2012/262363
Clinical Study

Diffuse Large B-Cell Lymphoma in Human T-Lymphotropic Virus Type 1 Carriers

1Department of Oncology and Radiotherapy, Edgardo Rebagliati Martins Hospital, Lima, Peru
2Department of Pathology, Edgardo Rebaglati Martins Hospital, Lima, Peru
3Department of Oncology, Daniel Alcides Carrion Hospital, Lima, Peru
4Division of Hematology and Oncology, The Miriam Hospital, Brown University Warren Alpert Medical School, Fain Building, 164 Summit Avenue, Providence, RI 02906, USA

Received 1 August 2011; Accepted 21 September 2011

Academic Editor: Kunihiro Tsukasaki

Copyright © 2012 Brady E. Beltran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Stein, R. Warnke, W. Chan et al., “Diffuse large B-cell lymphoma, not otherwise specified,” in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, S. Swerdlow et al., Ed., pp. 233–237, IARC Press, Lyon, France, 2008. View at Google Scholar
  2. S. Nakamura, E. Jaffe, and S. Swerdlow, “EBV positive diffuse large B-cell of the elderly,” in WHO Classification of Tumours of Haematopoietic and Lymphoid, S. Swerdlow et al., Ed., pp. 243–244, IARC Press, Lyon, France, 2008. View at Google Scholar
  3. K. Ohshima, M. Kikuchi, Y. I. Masuda et al., “Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: clinicopathological features,” Cancer Research, vol. 51, no. 17, pp. 4639–4642, 1991. View at Google Scholar · View at Scopus
  4. J. O. Alarcon, H. B. Friedman, S. M. Montano et al., “High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru,” Journal of Acquired Immune Deficiency Syndromes, vol. 42, pp. 604–609, 2006. View at Google Scholar
  5. C. Sanchez-Palacios, E. Gotuzzo, A. M. Vandamme, and Y. Maldonado, “Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women,” International Journal of Infectious Diseases, vol. 7, no. 2, pp. 132–137, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Kozuru, N. Uike, K. Muta, M. D. Tatsurou Goto, Y. Suehiro, and M. Nagano, “High occurrence of primary malignant neoplasms in patients with adult T- cell leukemia/lymphoma, their siblings, and their mothers,” Cancer, vol. 78, no. 5, pp. 1119–1124, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. P. Costa, L. M. Sumita, and A. C. Segurado, “Non-radioisotope detection of pol sequences of HTLV-1 proviral DNA: standardisation and sensitivity analysis,” Journal of Virological Methods, vol. 137, no. 1, pp. 29–33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Beltran, R. Salas, P. Quinones et al., “EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier,” Infectious Agents and Cancer, vol. 4, no. 1, article 10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. E. Gibson and E. D. Hsi, “Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype,” Human Pathology, vol. 40, no. 5, pp. 653–661, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Hoeller, A. Tzankov, S. A. Pileri, P. Went, and S. Dirnhofer, “Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations,” Human Pathology, vol. 41, no. 3, pp. 352–357, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Morales, B. Beltran, F. H. De Mendoza et al., “Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma,” Leukemia and Lymphoma, vol. 51, no. 1, pp. 66–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Park, J. Lee, H. K. Young et al., “The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma,” Blood, vol. 110, no. 3, pp. 972–978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Murata, S. Nakamura, H. Kato et al., “Epstein-Barr virus-related Hodgkin's disease showing B cell lineage in an immunosuppressive patient seropositive for HTLV-I,” Pathology International, vol. 47, no. 11, pp. 801–805, 1997. View at Google Scholar · View at Scopus
  14. M. Hirokawa, “Epstein-Barr virus-associated Hodgkin's disease in HTLV-I seropositive patients: a report of two cases,” Pathology International, vol. 48, no. 1, pp. 67–73, 1998. View at Google Scholar
  15. S. Shahnaz, D. Reich, D. Arévalo-Valencia, S. Kucinska, J. Tulczynska, and J. Fleischman, “HTLV-1-associated adult T cell leukemia lymphoma presenting as granulomatous pneumocystis jiroveci pneumonia (PJP) and hypercalcemia,” Journal of General Internal Medicine, vol. 22, no. 3, pp. 420–423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Tobinai, T. Ohtsu, M. Hayashi et al., “Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma,” Leukemia Research, vol. 15, no. 9, pp. 837–846, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. M. P. Thompson and R. Kurzrock, “Epstein-barr virus and cancer,” Clinical Cancer Research, vol. 10, no. 3, pp. 803–821, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Manel, J. L. Battini, and M. Sitbon, “Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1,” The Journal of Biological Chemistry, vol. 280, no. 32, pp. 29025–29029, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Yoshida, “Multiple viral strategies of HTLV-1 for dysregulation of cell growth control,” Annual Review of Immunology, vol. 19, pp. 475–496, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Suefuji, K. Ohshima, N. Hayabuchi, K. Nakamura, and M. Kikuchi, “HTLV-1 carriers with B-cell lymphoma of localized stage head and neck: prognosis, clinical and immunopathological features,” British Journal of Haematology, vol. 123, no. 4, pp. 606–612, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Ueda, Y. Maeda, T. Yamaguchi et al., “Influence of Epstein-Barr virus infection in adult T-cell leukemia,” Hematology, vol. 13, no. 3, pp. 154–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Ogata, T. Satou, R. Kawano et al., “High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for Adult T cell leukemia,” Journal of Medical Virology, vol. 83, no. 4, pp. 702–709, 2011. View at Publisher · View at Google Scholar
  23. M. Amano, K. Marutsuka, T. Sugimoto, T. Todaka, and M. Setoyama, “Epstein-Barr virus-associated primary central nervous system lymphoma in a patient with adult T-cell leukemia/lymphoma,” Journal of Dermatology, vol. 38, no. 6, pp. 575–580, 2011. View at Publisher · View at Google Scholar
  24. Y. Tanaka, T. Kondo, W. Kishimoto et al., “Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia,” The Japanese Journal of Clinical Hematology, vol. 49, no. 4, pp. 263–269, 2008. View at Google Scholar · View at Scopus